Strategies for seasonal influenza

Health

Strategies for seasonal influenza

James Chambers

Former senior editor

James is Bureau Chief for Monocle, Hong Kong. Prior to this he worked as a Senior Editor with The EIU's Thought Leadership team for over three years researching business, technology and cities. He has also written about business and technology for The World In 2015 and economist.com. James has previous experience from IR magazine, a finance publication, where he was research editor in London and Shanghai. Additionally he contributed to Legal Week, a weekly legal magazine, and worked on the FT Innovative Lawyers Awards in the US and Europe. James is an English law-qualified solicitor (currently non-practising) and holds post-graduate legal qualifications from BPP Law School and an LLP in Law from the London School of Economics.

Research Methodology

This report draws on two main sources for its research and findings:

In June 2013, The Economist Intelligence Unit surveyed 418 senior business executives from the US, the UK, Germany, France, Italy and Spain—one-half of whom are from the board or C-level (CEO, CFO, CIO, etc). Twenty industries are represented in this sample, with just over one-quarter (28%) of companies coming from financial services or manufacturing. Around one-half of these companies have more than 500 employees or more than US$500m in annual revenue.

Alongside the survey, we conducted a series of in-depth interviews with senior executives, academics and other experts, supplemented by the desk research of relevant third party publications. Our thanks are due to the following for their time and insights (listed alphabetically by organisation):

• William Fried, senior medical director, Aetna (US)
• Frank Fox, head of occupational health, Anglo American
• Stefan Lang, chief medical officer and head of occupational medicine and health protection department, BASF (Germany)
• Graham Johnson, clinical lead, nursing, for Bupa Health Clinics (UK)
• Andreas Tautz, chief medical officer, Deutsche Post DHL (Germany)
• Angus MacGregor, director of human resources, Eversheds (UK)
• Al Smith, corporate director, safety, Greyhound Lines (US)
• Doug Quarry, medical director, medical information and analysis, International SOS (UK)
• Rod Ratsma, head of UK business continuity management practice, Marsh Risk Consulting
• Jenny Hawker, health management consultant, Mercer UK
• Helen Darling, president and chief executive, National Business Group on Health (US)
• Philippe Aeschlimann, spokesman, Nestle SA (Switzerland)
• Gill Macleod, chief executive, RoonLane Medical (UK)
• Amy Costello, senior benefits analyst, Staples (US)
• Lisa Hamblet, vice president, Staples Facility Solutions, Staples (US)
• Judy Harvey, manager, corporate industrial hygiene and workplace safety program, United Technologies (US)
• Jonathan Van-Tam, School of Community Health Sciences, University of Nottingham (UK); consultant on pandemic influenza to the World Health Organization
• Janice Hartgens, global occupational health manager, UPS (US)
• Tim Stevenson, head of medical services, Virgin Atlantic Airways (UK)
• Tom Sondergeld, director of team member health benefits and well-being, Walgreens (US)
• Tim Brne, director of immunization services, Walgreens (US)

The report was written by Andrea Chipman and edited by James Chambers

Salutation*

First Name*

Last Name*

Job Title*

Company*

Industry*

Country*

Work Email*

Economist Impact is a part of the Economist Group.

Occasionally, we would like to keep you informed about our newly-released content, events, our best subscription offers, and other new product offerings from The Economist Group.

I wish to be contacted by email by the Economist Group:

Hidden blind submit

The Economist Group is a global organisation and operates a strict privacy policy around the world. Please see our privacy policy here.

Related content

Health

Value-based healthcare in Sweden: Reaching the next level

The need to get better value from healthcare investment has never been more important as ageing populations and increasing numbers of people with multiple chronic conditions force governments to make limited financial resources go further.

These pressures, along with a greater focus on patient-centred care, have raised the profile of VBHC, especially in European healthcare systems. Sweden, with its highly comprehensive and egalitarian healthcare system, has been a leader in implementing VBHC from the beginning, a fact that was underscored in a 2016 global assessment of VBHC published by The Economist Intelligence Unit.

This paper looks at the ways in which Sweden has implemented VBHC, the areas in which it has faced obstacles and the lessons that it can teach other countries and health systems looking to improve the value of their own healthcare investments.

Health

Breast cancer patients and survivors in the Asia-Pacific workforce

With more older women also working, how will the rising trend of breast cancer survivorship manifest in workplace policies, practices and culture? What challenges do breast cancer survivors face when trying to reintegrate into the workforce, or to continue working during treatment? How can governments, companies and society at large play a constructive role?

This series of reports looks at the situation for breast cancer survivors in Australia, New Zealand and South Korea. It finds that while progress has been made, more needs to be done, particularly in South Korea, where public stigma around cancer remains high.

Health

The Cost of Silence

Cardiovascular diseases levy a substantial financial toll on individuals, their households and the public finances. These include the costs of hospital treatment, long-term disease management and recurring incidence of heart attacks and stroke. They also include the costs of functional impairment and knock-on costs as families may lose breadwinners or have to withdraw other family members from the workforce to care for a CVD patient. Governments also lose tax revenue due to early retirement and mortality, and can be forced to reallocate public finances from other budgets to maintain an accessible healthcare system in the face of rising costs.

As such, there is a need for more awareness of the ways in which people should actively work to reduce their CVD risk. There is also a need for more primary and secondary preventative support from health agencies, policymakers and nongovernmental groups.

To inform the decisions and strategies of these stakeholders, The Economist Intelligence Unit and EIU Healthcare, its healthcare subsidiary, have conducted a study of the prevalence and costs of the top four modifiable risk factors that contribute to CVDs across the Asian markets of China, Australia, Hong Kong, Japan, Singapore, South Korea, Taiwan and Thailand.

Download the report to learn more.

Strategies for seasonal influenza

Health

Strategies for seasonal influenza

Social Share:

Social Share:

Research Methodology

Related content

Value-based healthcare in Sweden: Reaching the next level

Breast cancer patients and survivors in the Asia-Pacific workforce

The Cost of Silence